Lung cancer cell line HCC78 positive for ROS1 fusion is sensitive to the tyrosine kinase inhibitor, crizotinib (Bergethon, Pao, Ji, Chen, Iafrate, et al, submitted), indicating that ROS1 fusion is another potentially targetable mutant kinase for lung cancer. Here, ROS1 is linked to lung cancer.